These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 7047913)

  • 1. [Different types of insulin-secretion in diabetes mellitus in man].
    Ellorhaoui M; Verlohren HJ; Lohmann D
    Maghrib Tibbi; 1981 Mar; 3(1):515-25. PubMed ID: 7047913
    [No Abstract]   [Full Text] [Related]  

  • 2. [Aging and pancreatic secretion].
    Kosaka K; Haguro R; Odagiri R
    Horumon To Rinsho; 1969 Oct; 17(10):863-9. PubMed ID: 5390547
    [No Abstract]   [Full Text] [Related]  

  • 3. Suppression of glucagon secretion during a tolbutamide infusion in normal and noninsulin-dependent diabetic subjects.
    Pfeifer MA; Beard JC; Halter JB; Judzewitsch R; Best JD; Porte D
    J Clin Endocrinol Metab; 1983 Mar; 56(3):586-91. PubMed ID: 6337181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Behavior of the serum I.R.I. in persons with latent diabetes after endovenous tolbutamide load].
    Artenisio AC; Albanese MC; Allegra V; Alibrando S; Caruso A; Sprovieri M; Corsi V
    Folia Endocrinol; 1972 Aug; 25(4):300-11. PubMed ID: 4678219
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of long-term tolbutamide treatment on glucose tolerance and insulin secretion in maturity-onset diabetes without obesity.
    Lauvaux JP; Mandart G; Heymans G; Ooms HA
    Horm Metab Res; 1972 Mar; 4(2):58-62. PubMed ID: 5028221
    [No Abstract]   [Full Text] [Related]  

  • 6. [Types of insulin secretion in diabetes mellitus].
    Verlohren HJ; Vrahimis J; Lohmann D
    Dtsch Z Verdau Stoffwechselkr; 1975; 35(4):183-90. PubMed ID: 1227812
    [No Abstract]   [Full Text] [Related]  

  • 7. Stimulatory effects of tolbutamide infusion on plasma glucagon in insulin-dependent diabetic subjects.
    Bohannon NV; Lorenzi M; Grodsky GM; Karam JH
    J Clin Endocrinol Metab; 1982 Feb; 54(2):459-62. PubMed ID: 7054228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Laboratory diagnostic tests of early period of diabetes].
    Sieradzki J
    Przegl Lek; 1974; 31(0):suppl:70-4. PubMed ID: 4409946
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hepatic cirrhosis (non hemochromatosic) Diabetes mellitus. III. Secretion of insulin in cirrhotic patients tolerant and non tolerant to oral glucose overload].
    Cerdán Vallejo A; Jolin Buzo T; Sánchez Franco F; Ortíz Vázquez J
    Rev Clin Esp; 1974 Sep; 134(5):441-8. PubMed ID: 4438739
    [No Abstract]   [Full Text] [Related]  

  • 10. [Diminution of delay in insulin secretion in early diabetes mellitus with ongoing tolbutamide treatment].
    Nadeau A; Catellier C
    Union Med Can; 1974 Mar; 103(3):413-7. PubMed ID: 4820869
    [No Abstract]   [Full Text] [Related]  

  • 11. [Assessment of the B-cell function in diabetic patients by means of the determination of insulin secretion following glucose-tolbutamide stimulation].
    Jahnke KA; Reis HE; Jahnke K
    Med Welt; 1976 Nov; 27(47):2293-5. PubMed ID: 794618
    [No Abstract]   [Full Text] [Related]  

  • 12. [Quantitative and qualitative analysis of disorders of insulin-secretion in diabetic syndromes].
    Ellorhaoui M; Verlohren HJ
    Tunis Med; 1984 Dec; 62(8):615-8. PubMed ID: 6397884
    [No Abstract]   [Full Text] [Related]  

  • 13. Diet-induced improvement of abnormalities in insulin and glucagon secretion and in insulin receptor binding in diabetes mellitus.
    Savage PJ; Bennion LJ; Flock EV; Nagulesparan M; Mott D; Roth J; Unger RH; Bennett PH
    J Clin Endocrinol Metab; 1979 Jun; 48(6):999-1007. PubMed ID: 447806
    [No Abstract]   [Full Text] [Related]  

  • 14. [Insulin reserve in chronic alcoholics without pancreatitis and hepatic cirrhosis. Etiological role of alcohol in diabetes].
    Peña Yáñez A; López Luque A; Osorio J; del Arbol L; Rico Irles J; Palomo S
    Rev Clin Esp; 1978 Jul; 150(1-2):53-60. PubMed ID: 360321
    [No Abstract]   [Full Text] [Related]  

  • 15. Early insulin and glucagon response to subsequent pulses of arginine, glucose, and tolbutamide in normal man.
    Greco AV; Manna R; Ghirlanda G; Altomonte L; Rebuzzi AG; Bertoli A
    Am J Physiol; 1979 Feb; 236(2):E85-9. PubMed ID: 369391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Blood insulin and diabetes. I. Method of study--normal subjects--diabetic disease].
    Duprey J; Lubetzki J
    Pathol Biol (Paris); 1971 Mar; 19(5):311-31. PubMed ID: 4929994
    [No Abstract]   [Full Text] [Related]  

  • 17. [Abnormalities in glucagon-induced insulin secretion and hepatic glycogenolysis in diabetic patients not dependent upon insulin].
    Ege P; Jacobsen M
    Ugeskr Laeger; 1971 Oct; 133(43):2118-20. PubMed ID: 5124230
    [No Abstract]   [Full Text] [Related]  

  • 18. [Causes of insulin secretion disorders in non-insulin dependent diabetics. Comparison of in vivo results with examinations of isolated islet cells].
    Lohmann D; Jahr H; Verlohren HJ; Zühlke H
    Z Gesamte Inn Med; 1981 Jan; 36(2):47-51. PubMed ID: 7013297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A method of studying insulin secretion in humans: the glucose stimulation test, followed by tolbutamide].
    Vague P; Ramahandridona G; Vialettes B
    Nouv Presse Med; 1976 Dec; 5(4):3001-4. PubMed ID: 794823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the action of tolbutamide in normal man. 3. Interaction of tolbutamide with glucagon, aminophylline and arginine in stimulating insulin response.
    Widström A; Cerasi E
    Acta Endocrinol (Copenh); 1973 Mar; 72(3):532-44. PubMed ID: 4346919
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.